Scientia Vascular Revenue and Competitors
Estimated Revenue & Valuation
- Scientia Vascular's estimated annual revenue is currently $33.4M per year.
- Scientia Vascular's estimated revenue per employee is $251,000
- Scientia Vascular's total funding is $50M.
Employee Data
- Scientia Vascular has 133 Employees.
- Scientia Vascular grew their employee count by 9% last year.
Scientia Vascular's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Development Engineer | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Scientist | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP, Global Sales & Marketing | Reveal Email/Phone |
6 | VP Research And Development | Reveal Email/Phone |
7 | VP Quality | Reveal Email/Phone |
8 | VP Operations | Reveal Email/Phone |
9 | Director Cost Accounting | Reveal Email/Phone |
10 | Senior Director Regulatory Affairs | Reveal Email/Phone |
Scientia Vascular Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $77.6M | 309 | 28% | N/A | N/A |
#2 | $13.8M | 55 | -17% | N/A | N/A |
#3 | $397.8M | 1585 | 7% | N/A | N/A |
#4 | $35.9M | 143 | 15% | N/A | N/A |
#5 | $75M | 157 | 43% | $12.8M | N/A |
#6 | $6.5M | 26 | 0% | N/A | N/A |
#7 | $9.3M | 37 | 9% | N/A | N/A |
#8 | $37.4M | 149 | -1% | N/A | N/A |
#9 | $143.1M | 570 | 9% | N/A | N/A |
#10 | $10.3M | 41 | -15% | N/A | N/A |
What Is Scientia Vascular?
(SI-N-T-AH) IS LATIN FOR “KNOWLEDGE†and is the foundation for our study of the challenges of vascular access and our motivation to pursue new solutions. By adopting a first-principles approach, we collaborate with physician thought-leaders to develop innovative medical devices and therapies that are unconstrained by conventional design and optimized to address the evolving needs of interventional specialists. Collectively, our staff brings an extensive background and knowledge of medical devices, biopolymers, metals, coatings, microfabrication, manufacturing automation, and mechanical and electrical engineering to focus on new product development. Our management team is comprised of professionals from leading companies in the endovascular field who have played important roles leading to successful mergers and acquisitions, including Precision Vascular Systems by Boston Scientific. Scientia Vascular possesses and develops its own technologies, many of which are patented and form the basis for our proprietary product designs. At our headquarters near Salt Lake City, Utah, we design and manufacture all of our products under QMS, ISO and FDA standards and guidelines. What makes Scientia different? By overcoming the limitations of current access devices and therapies, our next-generation solutions allow interventional specialists to expand what's possible. Our patented technologies and proprietary designs allow conflicting physical properties to work in balance, resulting in unmatched access with precise control. Our team has also developed proprietary processes with the goal of automating manufacturing and providing greater consistency, resulting in products that perform without compromise.
keywords:N/A$50M
Total Funding
133
Number of Employees
$33.4M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Scientia Vascular News
Scientia Vascular, a Salt Lake City, UT-based commercial company offering a suite of interventional medical devices, raised $50M in growth equity financing. The round was led by Vivo Capital. The company intends to use the funds to accelerate sales, marketing, and new product development in bo ...
Scientia Vascular (“Scientia” or the “Company”), a rapidly growing commercial company focused on helping save patients’ lives with a suite of interventional medical devices, has raised $50M of growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment f ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25M | 157 | N/A | N/A |
#2 | $58.6M | 164 | -5% | N/A |
#3 | $45.5M | 169 | 9% | N/A |
#4 | $41.1M | 178 | 7% | N/A |
#5 | $60.6M | 190 | -6% | N/A |